Canada markets open in 6 hours 49 minutes

Processa Pharmaceuticals, Inc. (PCSA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.23+0.12 (+2.36%)
At close: 04:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 85.18M
Enterprise Value 66.19M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.13
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.64

Trading Information

Stock Price History

Beta (5Y Monthly) -0.30
52-Week Change 3-25.94%
S&P500 52-Week Change 322.00%
52 Week High 314.24
52 Week Low 35.01
50-Day Moving Average 37.04
200-Day Moving Average 37.85

Share Statistics

Avg Vol (3 month) 356.84k
Avg Vol (10 day) 337.43k
Shares Outstanding 515.72M
Implied Shares Outstanding 6N/A
Float 89.51M
% Held by Insiders 130.67%
% Held by Institutions 19.40%
Shares Short (Nov. 14, 2021) 491.51k
Short Ratio (Nov. 14, 2021) 41.95
Short % of Float (Nov. 14, 2021) 40.78%
Short % of Shares Outstanding (Nov. 14, 2021) 40.58%
Shares Short (prior month Oct. 14, 2021) 4112.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec. 22, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Dec. 22, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.49%
Return on Equity (ttm)-109.84%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-22.6M
Diluted EPS (ttm)-1.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.09M
Total Cash Per Share (mrq)1.22
Total Debt (mrq)101.54k
Total Debt/Equity (mrq)0.37
Current Ratio (mrq)16.85
Book Value Per Share (mrq)1.74

Cash Flow Statement

Operating Cash Flow (ttm)-8.27M
Levered Free Cash Flow (ttm)-3.42M